Hycom

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hycom

Property Description
Active ingredient Hyoscine Butylbromide (Butylscopolamine)
Form Oral tablet, Solution for injection
Pharmacological class Antispasmodic, Peripheral Anticholinergic Agent
General purpose Relief of visceral smooth muscle spasm and cramping
Origin Semisynthetic (Quaternary Ammonium Compound)

What Type of Medicine is Hycom?

Hycom is classified as a prescription pharmaceutical product that functions as a potent antispasmodic and a peripheral anticholinergic agent. Its core general purpose is to provide relief from acute pain and discomfort caused by involuntary smooth muscle cramps or visceral spasm within the abdominal and pelvic regions.

The active ingredient in Hycom is Hyoscine Butylbromide, also known by the synonym Butylscopolamine. This drug is recognized for its ability to reduce excessive, painful contractions. It belongs to the parasympatholytic group, which targets the involuntary nervous system to reduce the muscular contractions that manifest as spasms.

Hyoscine Butylbromide: Origin, Composition, and Forms

This medication is a single active ingredient product where Hyoscine Butylbromide is a semisynthetic derivative of the natural plant alkaloid Scopolamine. Chemically, it is identified as a quaternary ammonium compound, a structural feature that dictates its specific behavior in the body, primarily limiting its effects outside the digestive and urinary tracts.

Hycom is available in two distinct dosage form(s) to suit different therapeutic needs: the oral tablet and a solution for injection (parenteral presentation). These forms allow for flexible administration via the oral route for management or the intramuscular or intravenous routes for rapid, acute intervention.

How Hycom Generally Relieves Visceral Spasm

Hycom achieves its spasmolytic effect by selectively interrupting nerve signals in the smooth muscle tissue of organs, leading directly to smooth muscle relaxation. This drug is distinguished by its peripheral action, a key feature derived from its quaternary structure which prevents significant transfer across the blood-brain barrier. By physically relaxing the contracted muscle wall and disrupting the excessive signaling that causes cramping, Hyoscine Butylbromide focuses its therapeutic effect on the visceral tract, fulfilling its core general purpose of effective spasm relief.

Regulatory References

  1. World Health Organization
  2. National Library of Medicine

What side effects are possible with Hycom?

Possible Side Effects and Safety Information

The officially documented safety profile for Hyoscine Butylbromide (Hycom) is determined by its classification as a peripheral anticholinergic agent. Regulatory documents organize adverse reactions based on their frequency and the body system affected, ensuring transparent communication of known risks.


Adverse Reactions Classified by Frequency

Side effects are categorized by frequency observed in clinical data, as established by governmental regulatory standards:

  • Uncommon (affecting up to 1 in 100 people): Reactions commonly reported include dry mouth, tachycardia (increased heart rate), and various skin reactions (e.g., urticaria, pruritus).
  • Rare (affecting up to 1 in 1,000 people): The primary effect listed in this category is urinary retention.
  • Not Known (frequency cannot be estimated): This classification includes reports from post-marketing surveillance, such as anaphylactic shock (a severe allergic reaction, including fatal outcomes), decreased blood pressure (hypotension), mydriasis (pupil dilation), and increased intraocular pressure.

Serious Safety Considerations

Official labeling highlights several serious adverse reactions and safety constraints:

  • Hypersensitivity: The risk of anaphylactic shock and other severe allergic reactions is formally documented.
  • Cardiovascular Risk: Caution is required when administering the injectable form to patients with underlying cardiac disease (e.g., cardiac failure), as effects like tachycardia and hypotension can be more serious.
  • Structural Contraindications: The medication is contraindicated in patients with conditions such as narrow-angle glaucoma, megacolon, and mechanical stenosis in the gastrointestinal tract, due to the potential for severe complications stemming from its anticholinergic action.

Very rare central nervous system effects, including coma, hallucinations, and confusion, have been reported following the parenteral administration of the medicine, from which patients typically recovered after withdrawal.

Overdose and Emergency Response

Hyoscine Butylbromide (Hycom) overdose results from excessive peripheral anticholinergic activity, as documented in official regulatory sources. The clinical manifestations are characteristic of this over-activity, featuring signs such as tachycardia (fast heart rate), dry mouth, reddening of the skin, and drowsiness. Official labeling also documents the impairment of smooth muscle function, leading to urinary retention and inhibition of gastrointestinal motility, alongside ocular effects such as transient visual disturbances and accommodation disorders.

The regulatory profile explicitly identifies severe and potentially life-threatening outcomes, including respiratory paralysis and Cheynes-Stokes respiration, along with documented cardiovascular complications. Due to the risk of severe outcomes, government labeling mandates that immediate medical attention must be sought if an overdose is suspected, or if severe, unexplained abdominal pain persists or is accompanied by symptoms like fever, vomiting, or blood in stool.

Clinical management outlined in regulatory texts specifies symptomatic and supportive treatment. For oral overdosage, this includes procedures such as gastric lavage with activated charcoal and magnesium sulfate. Symptoms of overdose may respond to parasympathomimetics. Furthermore, interventions like catheterisation for urinary retention and intubation and artificial respiration for respiratory paralysis are documented as necessary supportive measures.

Therapeutic Uses of Hycom

Hycom is used for symptomatic relief in conditions characterized by intense, involuntary smooth muscle spasms. It is applied across therapeutic domains where additional supportive management is needed to address symptoms related to heightened physiological activity.

This medication is commonly used to help with acute and sudden episodes of cramp-like pain in the gastrointestinal, biliary, and renal systems. It also provides relief for recurrent abdominal cramping linked to functional conditions like Irritable Bowel Syndrome (IBS), as well as pronounced symptoms like severe menstrual cramping (primary dysmenorrhea).

“Hycom is relevant for managing symptoms that interfere with daily comfort, contributing to improved well-being during symptomatic periods.”

The medication supports the easing of the underlying spasm, contributing to improved comfort during acute episodes. It is also applied in clinical settings to assist with maintaining functional stability during specialized medical imaging or endoscopic procedures, which may assist the specialist in obtaining clearer views.


Quick Fact: Relief for Visceral Cramping

Eligibility and Restrictions for Use

The eligibility for using Hycom, whose active ingredient is Hyoscine Butylbromide, is strictly defined by regulatory documents, which list specific absolute contraindications and mandatory cautions.

Contraindicated Populations (Absolute Non-Eligibility)

Official labeling states that Hycom must not be used in patients with:

  • Hypersensitivity to the drug or its components.
  • Myasthenia gravis.
  • Untreated narrow-angle glaucoma.
  • Mechanical stenosis in the gastrointestinal tract (e.g., pyloric stenosis).
  • Paralytic or obstructive ileus or megacolon.
  • Prostatic hypertrophy with urinary retention (specifically for the parenteral injection form).
  • Tachycardia, angina, or cardiac failure (specifically for the parenteral injection form).

Age and Condition-Based Restrictions

The medicine is generally approved for Adults and Adolescents over 12 years. The oral tablets are approved for Children aged 6 to 12 years in many regions, but use is not recommended in children under 6 years of age. Older patients should use the medicine with caution [4.2].

Special Population Regulatory Status Constraint Detail
Pregnancy Not Recommended Precautionary measure due to limited human data [1.5].
Breastfeeding Not Recommended Insufficient data on excretion into human milk [1.5].
Cardiac Conditions Use with Caution Advised for patients with arrhythmias, hypertension, or coronary disease [1.1].
Anticoagulant Use Route Restriction Injection must not be given via the intramuscular (IM) route [1.1].

These official regulatory criteria determine who is eligible to use the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The concurrent use of Hycom with certain other substances can lead to an amplified effect, particularly increased drowsiness and central nervous system (CNS) depression. This additive effect is primarily a pharmacodynamic interaction when combining Hycom with other sedating agents.

Clinically Significant Interactions

The following product categories are associated with documented interactions, which may necessitate consultation with a healthcare professional or complete avoidance:

  • Alcoholic Beverages: It is a restriction to avoid alcoholic beverages entirely while using this product. The combination significantly increases the risk of enhanced CNS depression, leading to increased drowsiness, dizziness, and impairment.
  • Sedatives and Tranquilizers: Use with sedatives or tranquilizers may result in a combined depressant effect, greatly increasing sedation. Patients should ask a doctor or pharmacist before use if they are taking these types of medications.
  • Certain Prescription Drugs: Caution is required if the patient is taking a prescription drug for high blood pressure or depression. A doctor or pharmacist should be consulted prior to combining this product with these classes of medications to assess the individual risk and need for monitoring.

Mechanism of Action

The mechanism of Hyoscine Butylbromide is defined by its action as a competitive antagonist at muscarinic acetylcholine receptors (primarily the M3 subtype). These receptors are highly expressed on the smooth muscle of visceral organs and intramural ganglia.

This molecular engagement interrupts the signaling pathway where the neurotransmitter acetylcholine would normally trigger muscle contraction, leading to the molecular consequence of preventing the necessary release of intracellular calcium ( Ca^2+). The resulting modification of the parasympathetic nervous system activity at the effector site causes the smooth muscle wall in the gastrointestinal and urogenital tracts to relax. This cascade results in the modulation of overactive muscle tone and excessive peristaltic movement, which constitutes the primary physiological change resulting from the mechanism.

Chemically, the drug is a quaternary ammonium compound, a permanent charge that prevents it from crossing the blood-brain barrier in significant amounts. This structural constraint enforces a highly selective focus on peripheral autonomic pathways, restricting modulation of CNS functions.

Dosage and Administration Information

How to use Hycom — Official Administration Guidelines

Hycom is a brand name for a medicine containing Hyoscine Butylbromide (Scopolamine butylbromide), an anticholinergic antispasmodic agent. The official instructions for its use are governed by the specific guidelines for the active ingredient as detailed in authorized documentation.


Administration Scope

Feature Official Rule
Route of administration Oral (tablet)
Dosing schedule Adult dose: Typically 10 mg to 20 mg, repeated up to 3 to 4 times daily as needed. For Irritable Bowel Syndrome (IBS), a lower starting dose may be used, and may be increased if necessary.
Timing in relation to meals May be taken with or without food.
Preparation requirements Tablets must be swallowed whole with water. Do not chew or crush.
Age-group administration rules Not recommended for children under 6 years of age. Dosing for children 6 to 12 years is typically one tablet (10 mg) three times a day.
Missed-dose rules If a dose is missed, take it as soon as remembered, unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and take the next dose at the regular time. Do not take a double dose.
Special procedural conditions Should not be taken continuously for long periods of time. Worsening or persistent symptoms should be investigated by a healthcare professional.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern As-needed (up to 3–4 times daily)
Regulatory basis Governed by national regulatory authorities and standard patient information guidelines.
Use-context constraints Should not be used for extended periods without medical review.

Resulting Procedural Structure

Official step sequence:

  • Swallow the specified dose of the tablet whole with water. Do not break or crush it.
  • Repeat the dose as required, up to the maximum frequency determined by the dosing schedule (e.g., up to 3 or 4 times daily).
  • If a dose is missed, take it immediately unless the next scheduled dose is imminent; in this case, skip the missed dose and resume the normal schedule.

Connection to the overall use protocol: This administration protocol details the oral route of the tablet, the frequency (up to four times daily), and the procedural steps for swallowing the medication whole. It establishes age-specific restrictions for use and clarifies the rule against continuous long-term use without physician review, emphasizing that the medication is taken on an as-needed basis for symptomatic relief.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hycom


Evidence for Use in Acute Abdominal Cramping and Visceral Pain

The study of Hyoscine Butylbromide for symptoms of sudden, intense abdominal cramps and pain was conducted in numerous controlled clinical studies, primarily short-term Randomized Controlled Trials (RCTs). This type of research is considered high quality and is designed to compare study outcomes in participants receiving the compound against a placebo or other study comparators.

Researchers focused on measuring outcomes related to physical discomfort using standardized tools. The reported findings describe patterns observed in the studies, often tracking how patients' pain scores evolved over very short intervals, such as 30 minutes to a few hours, relative to the time of administration. The evidence is limited regarding the frequency or pattern of administration evaluated for sustained acute relief.


Evidence for Use in Irritable Bowel Syndrome (IBS) Symptoms

Research has explored outcomes related to Hyoscine Butylbromide in recurrent abdominal discomfort and pain in adults diagnosed with Irritable Bowel Syndrome (IBS). The evidence base includes systematic reviews and longer-duration trials that evaluated outcomes such as global symptom scores and pain frequency.

However, the certainty regarding this use remains low to moderate. Evidence quality varies across studies, and some published reviews have noted that the findings were mixed or inconsistent across the full landscape of antispasmodic research. There is also limited information for long-term outcomes, meaning the durability of response over many months of use is not fully established by the existing RCTs.


Evidence for Use During Diagnostic and Endoscopic Procedures

The study of Hyoscine Butylbromide in clinical settings focused on outcomes related to gastrointestinal muscular activity during medical examinations. This research explores temporary physiological imbalance and uses the injectable formulation in a controlled, supervised setting. Findings show patterns related to rapid relaxation of the smooth muscle tissue observed in these procedural settings. The evidence for the procedural setting is specific and offers limited insight into outcomes related to the use of the oral formulation for daily, fluctuating symptoms.


What Remains Uncertain or Under-Researched

Evidence highlights what is known—and what is still uncertain—about Hyoscine Butylbromide. A key limitation is that sample sizes were modest in some of the older trials, and evidence quality varies across studies for some indications. The full scope of outcomes related to systemic or functional imbalance outside of immediate symptom relief is not fully established. The research provides context but not individual predictions regarding a patient's response. The results apply only to the populations studied.

Key Studies & References

  1. Impact of Hyoscine Bromide Use on Polyp Detection Rate During Colonoscopy: A Systematic Review and Meta-Analysis
  2. Hyoscine butylbromide - eEML - Electronic Essential Medicines List (WHO)

Frequently Asked Questions (FAQ)

Common questions about Hycom (FAQ)

Q: How is Hycom different from [A common, similar drug name]?

Hycom is officially classified as a potent antispasmodic and a peripheral anticholinergic agent. This means it works by targeting involuntary muscle contractions in the abdomen and pelvis. The medication’s chemical structure is primarily defined to limit its action to these areas, which minimizes effects on the central nervous system.

Q: Do I need to change my diet while using Hycom?

Official administration guidance states that Hycom can be taken with or without food. There are no general dietary changes required. However, the main restriction described in the product information is the restriction of alcoholic beverages due to the risk of increased drowsiness and impairment.

Q: Are there any long-term effects of taking Hycom that have been studied?

Official administration guidelines state that continuous long-term use is not advised. Research data is often limited regarding long-term outcomes and safety. Symptoms that persist or worsen should be investigated.

Q: Why do some people take Hycom in the morning and others at night?

Hycom is structured to be an 'as-needed' (PRN) medicine, meaning its consumption pattern is based on when spasms or cramps occur. The timing of administration is therefore flexible and determined by the presence of the patient's symptoms, whether that is during the day or at night.

Q: Is Hycom safe to use if I have high blood pressure?

Caution is advised by official labeling for patients with certain pre-existing heart conditions, including hypertension (high blood pressure), and those taking specific prescription drugs for high blood pressure. Consultation with a healthcare professional is necessary to assess any individual risk before use.

Q: Can Hycom cause mood swings or changes in personality?

Very rare central nervous system effects, such as confusion, agitation, or hallucinations, have been reported in post-marketing surveillance. It is noted that these rare instances primarily occurred following the administration of the injectable form of the medicine.

Q: Is it normal to feel a little tired when first starting Hycom?

Drowsiness and dizziness are officially documented side effects. These risks are heightened when Hycom is combined with certain other substances, such as alcohol or sedatives. The product label specifies caution related to driving or operating machinery if drowsiness is experienced.

Q: Are there any common interactions that people often forget about with Hycom?

Product labeling emphasizes the risk of increased sedation when combining Hycom with alcohol or other medicines that depress the central nervous system. Official warnings specify caution is required with sedatives, tranquilizers, and certain prescription drugs for high blood pressure or depression due to the potential for additive effects.

Q: Can Hycom affect driving or operating machinery?

Due to the potential for side effects such as drowsiness, dizziness, or blurred vision, official advice recommends caution or avoidance of these activities if these effects are experienced, until you know how the medicine affects you.

Q: Can Hycom be taken with milk or juices?

The administration condition described in regulatory documents is that the tablets are taken whole with water. Given that the medication is generally permitted to be taken with or without food, the consumption of non-alcoholic liquids like milk or juice is not typically restricted by the product information.

Q: What are the general expectations for a patient starting Hycom?

The medicine’s intended effect, according to the product mechanism, is the relief of visceral smooth muscle spasms and pain. Patients should also be aware of the possibility of common, minor side effects mentioned in official documents, such as dry mouth or temporary changes in vision.

Q: Is Hycom considered a strong medicine?

Regulatory documents use pharmacological classifications rather than subjective terms like 'strong.' Hycom is officially described by its action as a potent antispasmodic and a peripheral anticholinergic agent, which refers to its specific and focused mechanism of action.

Q: Does Hycom work for conditions other than the main ones listed?

Hycom is only approved and evaluated by regulatory bodies for its stated indications, such as the relief of visceral spasms and symptoms of Irritable Bowel Syndrome (IBS). Regulatory documents do not address uses outside of these approved indications.

Q: How quickly should I expect Hycom to start working?

Studies and patient information indicate that the onset of action for the oral tablet is considered relatively rapid. Relief is sometimes reported to begin as early as 15 to 30 minutes after taking the dose.

Q: Does Hycom interact with over-the-counter pain relievers?

Official labeling does not list a specific interaction with standard over-the-counter pain relievers. However, the product label specifies caution is necessary with any medication that causes drowsiness, due to the risk of additive effects.

Q: What is the difference between Hycom and a supplement for the same condition?

Hycom is a prescription pharmaceutical product containing a chemically defined active ingredient, Hyoscine Butylbromide. As a pharmaceutical product, it is subject to rigorous regulatory approval processes and quality standards for medicines, unlike dietary supplements.

Q: Can Hycom affect my sleep schedule?

Yes, as sleep-related issues such as drowsiness or insomnia are sometimes noted as potential side effects. Caution is specifically advised when the medicine is used in combination with other central nervous system depressants, which can compound the risk.

Q: Is Hycom addictive or habit-forming?

Based on its pharmacological class and regulatory safety profile, Hycom is generally not considered an addictive or habit-forming medicine when it is taken at prescribed doses.

Q: What kind of research has been done on Hycom in children?

Clinical trials and evidence for the medicine have primarily focused on the adult population. Nonetheless, many regions have an approved dosage that may be used in children aged 6 to 12 years for specific indicated conditions.

Q: Does Hycom affect the way birth control works?

According to official product information and documented drug interaction studies, there are no known pharmacokinetic or pharmacodynamic interactions between Hycom and hormonal contraceptives that would reduce the effectiveness of birth control pills.

Q: What happens if I accidentally take more Hycom than intended?

In cases of accidental overdose, immediate professional medical attention is the official course of action described. Official documents list potential symptoms of overdose, which may include a very dry mouth, rapid heartbeat (tachycardia), and temporary visual disturbances.

Q: Can Hycom be used to help with energy levels?

Hycom is indicated only for the relief of visceral smooth muscle spasms and pain within the abdominal and pelvic regions. It is not approved or intended for use as a treatment to increase energy levels or manage fatigue.

Q: Does Hycom have an effect on kidney or liver function?

Official product labeling specifies that caution and monitoring are required for patients who have severe liver or kidney disease. Consultation with a healthcare provider is the described process to assess any individual risk.

Q: What does the research say about stopping Hycom suddenly?

As Hycom is typically taken on an as-needed basis for acute symptoms, there are generally no reported withdrawal or rebound symptoms associated with suddenly stopping the medication.

Q: How long after stopping Hycom does it take for the drug to leave my system?

Pharmacokinetic studies report that the half-life of elimination for the drug typically ranges between 6 to 10 hours. This means that the majority of the drug will be eliminated from the body within approximately one day after the last dose.

Q: If I have a mild side effect, does that mean I should stop taking Hycom?

If you experience any mild or unusual side effects, regulatory advice specifies that these should be reported to a doctor or pharmacist. Immediate medical help is advised to be sought only for severe symptoms, such as the signs of a serious allergic reaction.

How should Hycom be stored and disposed of?

Hycom (hyoscine butylbromide) must be stored in a dry place away from excessive heat, moisture, and direct light. The required storage temperature is generally at or below 30 C. It is mandatory to keep the medicine from freezing to prevent product degradation.

Packaging and Stability

Tablets should remain in their original packaging. The injectable solution must be used immediately after opening the ampoule, and any unused portion must be discarded. Do not use the medicine past the expiry date.

Child Safety and Disposal

The product must be stored securely, out of the sight and reach of children. Unused or expired medication must be disposed of in accordance with local requirements, typically by returning it to a pharmacist. Medicines should not be disposed of via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hycom found in:

A-Z Index: